USMLE® Step 1 & 2

Kaplan USMLE Step 1: Identifying cardiovascular status

. 5 MIN READ

If you’re preparing for the United States Medical Licensing Examination® (USMLE®) Step 1 exam, you might want to know which questions are most often missed by test-prep takers. Check out this example from Kaplan Medical, and read an expert explanation of the answer. Also check out all posts in this series.

Succeed in medical school with AMA benefits

  • Exclusive education programs & key study guides to help you thrive.
  • Access to JAMA Network™, ClassPass gym discounts & more!

Supporting you today as a medical student. Protecting your future as a physician.

The AMA and Kaplan have teamed up to support you in reaching your goal of passing the USMLE® or COMLEX-USA®. If you're looking for additional resources, Kaplan provides free access to tools for pre-clinical studies, including Kaplan’s Lecture Notes series, Integrated Vignettes, Shelf Prep and more.

A previously healthy 64-year-old woman is brought to the emergency department because of substernal chest pain, nausea, diaphoresis, and fatigue. Her temperature is 37.1°C (98.8°F), pulse is 96 beats per minute, respirations are 18 a minute, and blood pressure is 138/92 mm Hg. A cardiac examination reveals an S4 gallop but is otherwise unremarkable. Her lungs are clear. Her ECG shows a ST-segment elevation in the inferior chest leads (leads II, III and aVF). In the figure, “N” denotes cardiovascular status in a normal, healthy person at rest, and the circled numerals denote various deviations from this state.

Step 1 card status 1

Which of the following choices best corresponds to this patient's cardiovascular status?

A. Status point 1.

B. Status point 2.

C. Status point 3.

D. Status point 4.

E. Status point 5.

F. Status point 6.

 

 

 

 

 

 

 

 

 

 

 

 

 

The correct answer is F.

The figure shows a family of intersecting cardiac function curves (CFCs, also known as Starling curves) and vascular function curves (VFCs). The intersection of two such curves defines cardiovascular status. Thus, in a normal, healthy individual, a right atrial pressure (RAP) of 2 mm Hg supports a cardiac output (CO) of ~5L and vice versa.

Related coverage

4 essential tips for your final weeks of Step 1 study

The patient is experiencing an acute myocardial infarction, as evidenced by ST-segment elevation in the inferior chest leads. ST-segment elevation is caused by an injury current that flows between ischemic and healthy areas of the resting myocardium. Infarction reduces overall myocardial contractility, causing the CFC to shift downward and to the right (see [a] in the figure below).

Step 1 card status 2

Reduced cardiac inotropy causes CO and mean arterial pressure (MAP) to fall, initiating a baroreflex. Sympathetic nervous system activation has four principal effects, all intended to restore MAP to normal levels:

  • Increases heart rate.
  • Increases contractility within the healthy regions of the myocardium.
  • Constricts veins.
  • Raises systemic vascular resistance (SVR).

Venoconstriction decreases the capacity of the venous reservoirs and raises central venous pressure, forcing blood forward toward the right atrium. RAP rises as a result, increasing left ventricular preload and thereby helping to compensate for the loss of inotropy. Venoconstriction shifts the VFC upward (see step [b] in the figure above) and establishes a new mean systemic filling pressure (MSFP). The MSFP is the pressure that exists in all parts of the vasculature after CO has been arrested and the arterial and venous compartments have come into equilibrium. MSPF is a measure of the "tightness" of the vasculature.

Sympathetic activation also restricts blood flow to non-essential circulations to help preserve MAP. This action decreases venous return and causes the VFC to rotate counterclockwise (step [c] in the figure above) without changing MSFP.

Sympathetic activation following an ischemic event helps maintain MAP until long-term pressure-regulatory pathways have had a chance to activate fully (about 8–24 hrs). This involves expanding extracellular fluid (ECF) volume through activation of the renin-angiotensin-aldosterone system (RAAS).

The figure below summarizes some common scenarios that cause shifts in the CFC and VFC.

Step 1 card status 3

Choice A: Point 1 falls on the intersection of a normal VFC and a CFC that has been shifted upward through an increase in ventricular inotropy, as might be expected from administering a beta-agonist.

Choice B and C: Point 2 falls on a VFC that has shifted downward and rotated clockwise, suggesting a simultaneous decrease in venous and arterial tone. Such changes occur when sympathetic output falls, but the lack of any change in the CFC makes this intersection unlikely physiologically. Instead, one would expect to see cardiac inotropy and heart rate fall in parallel with vascular tone, such as seen at the intersection indicated by point 3.

Related Coverage

Kaplan USMLE Step 1 prep: 4 stumpers about middle-aged adults

Choice D: Point 4 might represent the cardiovascular status of an individual engaged in mild anaerobic exercise, such as weightlifting. Cardiac inotropy has increased, along with venoconstriction and an increase in SVR. 

Subscribe and succeed in medical school

Get tips and insider advice from the AMA on succeeding in medical school—delivered to your inbox.

Medical student sitting on a stack of textbooks

Choice E: The intersection represented by point 5 is unlikely physiologically. The VFC has shifted upward and rotated counterclockwise, indicating venoconstriction (or an ECF volume increase) and an increase in SVR. Cardiac function is unaffected.

  • The intersection of a CFC and VFC define the amount of CO that can be supported by a given RAP (and vice versa).
  • Myocardial infarction decreases cardiac inotropy, thereby reducing CO and MAP.
  • Venoconstriction can help compensate for the loss of inotropy by raising RAP. The extent to which venoconstriction compensates is determined from the intersection of the post-infarction CFC and the venoconstriction-modified VFC.

For more prep questions on USMLE Steps 1, 2 and 3, view other posts in this series.

FEATURED STORIES